Citius Pharmaceuticals, Inc. Current Liabilities
Citius Pharmaceuticals, Inc. (CTXR) had Current Liabilities of $51.65 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $51.65M.
- 2026-03-31: Liabilities, Current $55.02M.
- 2025-12-31: Liabilities, Current $38.21M.
- 2025-09-30: Liabilities, Current $44.91M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $51.65M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $55.02M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $38.21M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $44.91M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $51.84M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $49.88M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $44.81M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $35.81M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $4.15M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $4.17M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $5.58M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $5.78M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $5.79M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.21M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $4.54M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $4.53M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $4.46M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.02M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $7.34M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $3.98M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $3.60M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.98M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.55M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $4.10M 10-K · filed 2021-12-15 | |
| 2020-06-30 | $3.61M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.11M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $3.63M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $4.61M 10-K · filed 2020-12-16 | |
| 2019-06-30 | $4.04M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.36M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $3.90M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $3.18M 10-K · filed 2019-12-16 | |
| 2018-06-30 | $2.19M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.56M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $2.62M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $2.47M 10-K · filed 2018-12-11 | |
| 2017-06-30 | $9.97M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $7.34M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $6.32M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $5.18M 10-K · filed 2017-12-13 | |
| 2016-06-30 | $4.85M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.35M 10-Q · filed 2016-05-20 | |
| 2015-12-31 | $1.94M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $1.38M 10-K · filed 2016-12-23 | |
| 2015-06-30 | $2.14M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $1.68M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $1.65M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $2.30M 10-K · filed 2015-12-14 | |
| 2014-06-30 | $31.35K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $25.05K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.32M 10-KT · filed 2014-12-29 | $21.00K 10-Q · filed 2014-02-19 |
| 2013-09-30 | $14.69K 10-Q · filed 2014-08-14 | |
| 2013-06-30 | $61.95K 10-Q · filed 2013-09-18 | |
| 2013-03-31 | $57.56K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $47.37K 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $45.98K 10-K · filed 2014-02-06 | |
| 2012-06-30 | $40.63K 10-Q · filed 2012-08-17 | |
| 2012-03-31 | $33.64K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $26.63K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $24.05K 10-K · filed 2013-01-15 | |
| 2011-06-30 | $21.15K 10-Q · filed 2011-08-26 | |
| 2010-09-30 | $0.00 10-Q · filed 2011-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |